Jerry Ware
Professor
Faculty Researcher
Physiology & Cell Biology, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Jerry Ware's research primarily investigates the role of platelets in various disease states, with a particular focus on chronic kidney disease (CKD) and liver disease. His work explores how platelet function and count are altered in patients with advanced CKD and how these changes contribute to inflammation and disease progression. Ware has published studies examining the inflammatory dysregulation associated with CKD and comparing the effects of different antiplatelet medications, such as ticagrelor and clopidogrel, on platelet aggregation and inflammatory markers in these patients.
Beyond CKD, Ware's research extends to other conditions, including NASH (non-alcoholic steatohepatitis) and liver cancer, where platelets and specific platelet glycoproteins like GPIbα are implicated as mediators and potential therapeutic targets. He also studies the involvement of platelet-GPVI in the axis driving systemic sclerosis. His laboratory utilizes murine models, including genetically modified mice, to investigate these complex biological processes. Ware has received significant funding for his research, including a substantial NIH grant focused on partnerships for biomedical research in Arkansas and another for studying platelets in radiation-induced immune dysregulation. His scholarly output is marked by a high citation count and an h-index of 60 across over 200 publications.
Metrics
- h-index: 60
- Publications: 220
- Citations: 13,312
Selected Publications
-
Platelet glycoprotein <scp>VI</scp> modulates leukocyte characteristics in sepsis‐induced systemic inflammatory response in male mice (2026)
-
Identification and Characterization of Platelet Surface-membrane-derived Microparticles before and after Total-body Irradiation (2025)
-
Contrasting Effects of Platelet GPVI Deletion Versus Syk Inhibition on Mouse Jugular Vein Puncture Wound Structure (2025)
-
A GPVI-platelet-neutrophil-NET axis drives systemic sclerosis (2025)
-
OC 10.3 Platelets Mediate Intracranial Aneurysm Formation and Rupture in Mice (2023)
-
Platelet Count and Platelet Volume in Patients with CKD (2023)
-
438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease (2023)
-
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease (2023)
-
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study (2022)
-
Murine models of glycoprotein Ib-IX (2022)
-
Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer (2022)
-
Platelet glycoprotein Ibα provides radiation protection (2021)
-
Role of Platelets in Chronic Kidney Disease (2021)
-
Calcium Ion Chelation Preserves Platelet Function During Cold Storage (2020)
-
Hemostasis vs. homeostasis: Platelets are essential for preserving vascular barrier function in the absence of injury or inflammation (2020)
Federal Grants 2 $4,674,158 total
Grants & Funding
As listed on this researcher's institutional profile. Federal awards with verified records are shown above.
- Leukocyte-platelet modulation of the systemic inflammatory response NIH Principal Investigator
- Transgenic analysis of platelet receptor expression NIH Principal Investigator
- Murine Hemostatic Properties of Thrombosomes DHHS - Biomedical Advanced Research and Development Authority via Cellphire, Inc. Principal Investigator
- In vivo, noninvasive, ultrasensitive photoacoustic detection of early breast cancer metastasis in bone US Department of the Army Principal Investigator
- Characterization and Analysis of Platelet Septins NIH Principal Investigator
- Platelet-leukocyte regulation of inflammatory responses- Resubmission- Resubmission American Heart Association Co-Investigator
- Platelet glycoprotein Ib-IX and malignancy US Department of the Army Principal Investigator
- Resubmission: Structure/Function Determinants of Puncture Wound Thrombus Formation NIH Co-Investigator
- Center for Studies of Host Response to Cancer Therapy NIH Co-Investigator
- Developmental Research Project Program NIH/NIGMS Other
- Platelet glycoprotein VI dependent microparticle formation NIH Principal Investigator
Collaboration Network
Top Collaborators
- Role of Platelets in Chronic Kidney Disease
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- Platelet Count and Platelet Volume in Patients with CKD
- 438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease
- Role of Platelets in Chronic Kidney Disease
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- Platelet glycoprotein Ibα provides radiation protection
- Platelet glycoprotein <scp>VI</scp> modulates leukocyte characteristics in sepsis‐induced systemic inflammatory response in male mice
- Role of Platelets in Chronic Kidney Disease
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- Platelet Count and Platelet Volume in Patients with CKD
- Role of Platelets in Chronic Kidney Disease
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- Platelet glycoprotein Ibα provides radiation protection
- Identification and Characterization of Platelet Surface-membrane-derived Microparticles before and after Total-body Irradiation
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- 438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- Platelet Count and Platelet Volume in Patients with CKD
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- 438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease
- Role of Platelets in Chronic Kidney Disease
- Platelet glycoprotein Ibα provides radiation protection
- Platelet glycoprotein Ibα provides radiation protection
- Platelet glycoprotein Ibα provides radiation protection
Similar Researchers
Based on overlapping research topics